Resistance to mineralocorticoids in wistar-furth rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 3 41-3, 1997, Pages

  Ullian, Michael E ^a,b   Islam, Muhammad M ^a   Robinson, Christopher J ^a   Fitzgibbon, Wayne R ^a   Tobin, Eric T ^a   Paul, Richard V ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

glucocorticoids; hypertension; kidneys; vasculature; vasoconstrictors

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; CITRATE SYNTHASE; DEOXYCORTICOSTERONE ACETATE; DEXAMETHASONE; MINERALOCORTICOID;

ANIMAL CELL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HORMONE ACTION; HYPERTENSION; KIDNEY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0030938640     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.3.h1454     Document Type: Article

References (32)

1. Adam, W. R., A. G. Ellis, and B. A. Adams. Aldosterone is a physiologically significant kaliuretic hormone. Am. J. Physiol. 252 (Fluid Electrolyte Physiol. 21): F1048-F1054, 1987.
2. Alexander, E. A., and N. G. Levinsky. An extrarenal mechanism of potassium adaption. J. Clin. Invest. 47: 740-748, 1968.
3. Bockman, C. S., W. B. Jeffries, W. A. Pettinger, and P. W. Abel. Endothelium, vasopressin receptors, and resistance to DOCA-salt hypertension. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H15-H21, 1993.
4. Bruner, C. A. Vascular responsiveness in rats resistant to aldosterone-salt hypertension. Hypertension 20: 59-66, 1992.
5. Couture, R., and D. Regoli. Vascular reactivity to angiotensin and noradrenaline in rats maintained on a sodium free diet or made hypertensive with desoxycorticosterone acetate and salt. Clin. Exp. Hypertens. 2: 25-43, 1980.
6. Field, M. J., B. A. Stanton, and G. H. Giebisch. Differential acute effects of aldosterone, dexamethasone and hyperkalemia on distal tubular potassium secretion in the rat kidney. J. Clin Invest. 74: 1792-1802, 1984.
7. Funder, J. W., P. T. Pearce, R. Smith, and A. I. Smith. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585, 1988.
8. Jeffries, W. B., S. McArdle, C. Bockman, P. W. Abel, and W. A. Pettinger. Vasopressin response in collecting ducts of rats resistant to mineralocorticoid hypertension. Hypertension 17: 63-71, 1991.
9. Kirsten, R., and E. Kirsten. Redox state of pyridine nucleotides in renal response to aldosterone. Am. J. Physiol. 223: 229-235, 1972.
10. Kornel, L., C. Ramsay, N. Kanamarlapudi, T. Travers, and W. Packer. Evidence for the presence in arterial walls of intracellular-molecular mechanism for action of mineralocorticoids. Clin. Exper. Hypertens. Part A Theory Pract. 4: 1561-1582, 1982.
11. Law, P. Y., and I. S. Edelman. Induction of citrate synthase by aldosterone in the rat kidney. J. Membr. Biol. 41: 41-64, 1978.
12. Longhurst, P. A., P. J. Rice, D. A. Taylor, and W. W. Fleming. Sensitivity of caudal arteries and the mesenteric vascular bed to norepinephrine in DOCA-salt hypertension. Hypertension 12: 133-142, 1988.
13. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
14. Marver, D., and M. J. Schwartz. Identification of mineralocorticoid target sites in the isolated rabbit cortical nephron. Proc. Natl. Acad. Sci. USA 77: 3672-3676, 1980.
15. Meyer, W. J., and N. R. Nichols. Mineralocorticoid binding in cultured smooth muscle cells and fibroblasts from rat aorta. J. Steroid Biochem. 14: 1157-1168, 1981.
16. Molteni, A., P. A. Nickerson, S. Gallant, and A. C. Brownie. Resistance of W/Fu rats to adrenal regeneration hypertension. Proc. Soc. Exp. Biol. Med. 150: 80-84, 1975.
17. Monney, M., P. A. Schlegel, and H. R. Brunner. Influence of sodium diet and deoxycorticosterone on the response to norepinephrine, lysine-vasopressin and angiotensin II of isolated perfused rat mesenteric arteries. Clin. Exp. Hypertens. Part A Theory Pract. 5: 1735-1747, 1983.
18. Murphy, T. J., R. W. Alexander, K. K. Griendling, M. S. Runge, and K. E. Bernstein. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature Lond. 351: 233-236, 1991.
19. Pan, Y. J., and D. B. Young. Experimental aldosterone hypertension in the dog. Hypertension 4: 279-287, 1982.
20. Perry, P. A., and R. C. Webb. Agonist-sensitive calcium stores in arteries from steroid hypertensive rats. Hypertension 17: 603-611, 1991.
21. Schiffrin, E. L., D. J. Franks, and J. Gutkowska. Effect of aldosterone on vascular angiotensin II receptors in the rat. Can. J. Physiol. Pharmacol. 63: 1522-1527, 1985.
22. Schiffrin, E. L., J. Gutkowska, and J. Genest. Effect of angiotensin II and deoxycorticosterone infusion on vascular angiotensin II receptors in rats. Am. J. Physiol. 246 (Heart Circ. Physiol. 15): H608-H614, 1984.
23. Schiffrin, E. L., F. S. Thome, and J. Genest. Vascular angiotensin II receptors in renal and DOCA-salt hypertensive rats. Hypertension 5, Suppl. V: V16-V21, 1983.
24. Sciotti, V., and S. Gallant. Resistance to mineralocorticoid-induced hypertensive vascular disease. Hypertension 10: 176-180, 1987.
25. Scott, B. A., B. Lawrence, H. H. Nguyen, and W. J. Meyer. Aldosterone and dexamethasone binding in human arterial smooth muscle cells. J. Hypertens. 5: 739-744, 1987.
26. Stanton, B., G. Giebisch, G. Klein-Robbenhaar, J. Wade, and R. DeFronzo. Effects of adrenalectomy and chronic adrenal corticosteroid replacement on potassium transport in rat kidney. J. Clin. Invest. 75: 1317-1326, 1985.
27. Stanton, B., A. Janzen, G. Robbenhaar, R. DeFronzo, G. Giebisch, and J. Wade. Ultrastructure of rat initial collecting tubule: effect of adrenal corticosteroid treatment. J. Clin Invest 75: 1327-1334, 1985.
28. 2+ efflux in arteries from deoxycorticosterone acetate hypertensive rats. Hypertension 19: 734-738, 1992.
29. Ullian, M. E., and J. J. Fine. Mechanisms of enhanced angiotensin II-stimulated signal transduction in vascular smooth muscle by aldosterone. J. Cell. Physiol. 161: 201-208, 1994.
30. Ullian, M. E., F. N. Hutchison, D. J. Hazen-Martin, and T. A. Morinelli. Angiotensin II-aldosterone interactions on protein synthesis in vascular smooth muscle cells. Am. J. Physiol. 264 (Cell Physiol. 33): C1525-C1531, 1993.
31. Ullian, M. E., J. R. Schelling, and S. L. Linas. Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses. Hypertension 20: 67-73, 1992.
32. Whitworth, J. A. Mechanisms of glucocorticoid-induced hypertension. Kidney Int. 31: 1213-1224, 1987.